HeimBBN • SWX
add
Bellevue Group AG
Við síðustu lokun
14,75 CHF
Dagbil
14,50 CHF - 14,80 CHF
Árabil
11,05 CHF - 24,30 CHF
Markaðsvirði
195,19 m. CHF
Meðalmagn
9,95 þ.
V/H-hlutf.
13,08
A/V-hlutfall
7,93%
Aðalkauphöll
SWX
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
(CHF) | jún. 2024info | Breyting á/á |
---|---|---|
Tekjur | 18,41 m. | -11,31% |
Rekstrarkostnaður | 13,73 m. | -10,56% |
Nettótekjur | 3,72 m. | -7,22% |
Hagnaðarhlutfall | 20,18 | 4,61% |
Hagnaður á hvern hlut | — | — |
EBITDA | — | — |
Virkt skatthlutfall | 17,26% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
(CHF) | jún. 2024info | Breyting á/á |
---|---|---|
Reiðufé og skammtímafjárfestingar | 30,49 m. | 100,63% |
Heildareignir | 138,75 m. | -4,69% |
Heildarskuldir | 22,05 m. | -24,81% |
Eigið fé alls | 116,70 m. | — |
Útistandandi hlutabréf | 13,20 m. | — |
Eiginfjárgengi | 1,67 | — |
Arðsemi eigna | 10,71% | — |
Ávöxtun eigin fjár | — | — |
Peningaflæði
Breyting á handbæru fé
(CHF) | jún. 2024info | Breyting á/á |
---|---|---|
Nettótekjur | 3,72 m. | -7,22% |
Handbært fé frá rekstri | 3,65 m. | 137,31% |
Reiðufé frá fjárfestingum | — | — |
Reiðufé frá fjármögnun | -8,10 m. | 45,85% |
Breyting á handbæru fé | -4,17 m. | 83,13% |
Frjálst peningaflæði | — | — |
Um
Bellevue Group AG, headquartered in Zurich, is a listed investment management corporation from Switzerland. Bellevue Group consists of the subsidiaries Bellevue Asset Management, Bellevue Private Markets and StarCapital. It has 9,6 billion Swiss francs Assets Under Management Around 80% of clients assets are in healthcare investments. Bellevue Group is also active in alternative investments and private equity, including co-investments in private domestic small and medium-sized enterprises. In this business area, client assets under management were 1.0 billion francs as of mid-2021.
Bellevue Group is among the largest investors in the health care segment worldwide. It has subsidiaries in Germany, UK and USA, and is focusing on platform companies with products in phase two trials or later who preferably develop technologies that can be applied in multiple ways. One of the Bellevue Asset Management teams manages the BB Biotech investment company. The former investment company BB Medtech, which was converted into an equity fund at the end of September 2009, is also managed by Bellevue Asset Management. Wikipedia
Framkvæmdastjóri
Stofnsett
1993
Vefsvæði
Starfsfólk
88